Detalles de la búsqueda
1.
Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.
Br J Cancer
; 127(3): 569-576, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35440668
2.
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial.
Prostate
; 81(6): 326-338, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33636027
3.
Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
J Urol
; 202(4): 732-741, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216253
4.
Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 120(5B): E30-E44, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27539393
5.
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
BMC Cancer
; 16(1): 744, 2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658492
6.
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
NPJ Precis Oncol
; 5(1): 76, 2021 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34385567
7.
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide.
Clin Cancer Res
; 27(14): 4077-4088, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820782
8.
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Clin Cancer Res
; 27(5): 1391-1398, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262136
9.
Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer.
J Circ Biomark
; 9: 13-19, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33717359
10.
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer.
Cancer Res
; 80(22): 4892-4903, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816908
11.
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer.
JCO Precis Oncol
; 32019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32832835
12.
Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
Oncotarget
; 9(47): 28561-28571, 2018 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29983880
13.
Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.
Cancer Res
; 77(20): 5687-5698, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28819021
14.
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer.
Clin Cancer Res
; 22(6): 1510-9, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26671992
15.
Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis.
NPJ Precis Oncol
; 5(1): 84, 2021 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518634
16.
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.
JAMA Oncol
; 2(11): 1441-1449, 2016 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27262168
Resultados
1 -
16
de 16
1
Próxima >
>>